Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2013 AND VI 12 AND IP 2
Results: 23
1
2
Target watch: Drugging the epigenome.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 92, doi. 10.1038/nrd3943
- By:
- Publication type:
- Article
3
Cancer: Tuning anticancer T cells.
- Published in:
- 2013
- By:
- Publication type:
- journal article
4
Neurodegenerative disease: Targeting pre-existing plaques in AD.
- Published in:
- 2013
- By:
- Publication type:
- journal article
5
Computational chemistry: Homing in on desired drug properties.
- Published in:
- 2013
- By:
- Publication type:
- journal article
6
Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 103, doi. 10.1038/nrd3931
- By:
- Publication type:
- Article
7
Mike Yeadon. Interview with Charlotte Harrison.
- Published in:
- 2013
- By:
- Publication type:
- Interview
8
Neuromuscular disorders: Reducing androgen receptor-mediated toxicity.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 102, doi. 10.1038/nrd3951
- By:
- Publication type:
- Article
9
Beyond magic bullets: true innovation in health care.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 85, doi. 10.1038/nrd3944
- By:
- Publication type:
- Article
10
Bone disorders: A new promoter of bone regeneration.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 102, doi. 10.1038/nrd3949
- By:
- Publication type:
- Article
11
Advances in targeting cell surface signalling molecules for immune modulation.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 130, doi. 10.1038/nrd3877
- By:
- Publication type:
- Article
12
Mike Yeadon.
- Published in:
- 2013
- Publication type:
- Interview
13
Targeting eosinophils in allergy, inflammation and beyond.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 117, doi. 10.1038/nrd3838
- By:
- Publication type:
- Article
14
Infectious disease: A broad protozoan drug target?
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 102, doi. 10.1038/nrd3950
- By:
- Publication type:
- Article
15
Clinical targeting of the TNF and TNFR superfamilies.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 147, doi. 10.1038/nrd3930
- By:
- Publication type:
- Article
16
2012 FDA drug approvals.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 87, doi. 10.1038/nrd3946
- By:
- Publication type:
- Article
17
Neurological disease: Inflammasome activation in Alzheimer's disease.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 102, doi. 10.1038/nrd3952
- By:
- Publication type:
- Article
18
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 94, doi. 10.1038/nrd3948
- By:
- Publication type:
- Article
19
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 91, doi. 10.1038/nrd3947
- Publication type:
- Article
20
Anticancer drugs: Assault on MALT1.
- Published in:
- 2013
- By:
- Publication type:
- journal article
21
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 83, doi. 10.1038/nrd3945
- Publication type:
- Article
22
Antibacterial drugs: New antibiotics on the horizon?
- Published in:
- 2013
- By:
- Publication type:
- journal article
23
Smoking cessation drugs market.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 97, doi. 10.1038/nrd3914
- By:
- Publication type:
- Article